TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 71 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $207,179 | -100.0% | 5,494 | -35.2% | 0.00% | – |
| Q4 2021 | $425,083,000 | -26.0% | 8,483 | -6.1% | 0.00% | – |
| Q3 2021 | $574,706,000 | +186.2% | 9,032 | +223.6% | 0.00% | – |
| Q2 2021 | $200,840,000 | -45.0% | 2,791 | -43.6% | 0.00% | – |
| Q1 2021 | $365,063,000 | +24.4% | 4,950 | +23.8% | 0.00% | – |
| Q4 2020 | $293,460,000 | -86.5% | 3,997 | -79.3% | 0.00% | -100.0% |
| Q3 2017 | $2,178,298,000 | +0.7% | 19,330 | +0.2% | 0.00% | 0.0% |
| Q2 2017 | $2,162,310,000 | -3.7% | 19,296 | +0.2% | 0.00% | 0.0% |
| Q1 2017 | $2,245,752,000 | +148723.9% | 19,257 | +34.3% | 0.00% | 0.0% |
| Q4 2016 | $1,509,000 | -30.7% | 14,335 | -27.3% | 0.00% | 0.0% |
| Q3 2016 | $2,179,000 | +4.9% | 19,719 | +38.1% | 0.00% | 0.0% |
| Q2 2016 | $2,078,000 | +350.8% | 14,274 | +343.2% | 0.00% | +100.0% |
| Q1 2016 | $461,000 | -4.4% | 3,221 | +3.2% | 0.00% | 0.0% |
| Q4 2015 | $482,000 | – | 3,121 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |